Core Logic - The company has over 20 years of experience in the biological laboratory consumables sector, focusing on biological culture and liquid handling, with leading technical strength and a comprehensive product matrix. The company is expected to maintain rapid growth and become a global leader in laboratory consumables [1] Group 1: Overseas Market - The company is leveraging an ODM model to penetrate the global biological laboratory consumables supply chain, establishing stable partnerships with international leaders like VWR and Thermo Fisher, and exporting products to over 70 countries. The company is enhancing its brand image as "reliable quality" and "outstanding cost performance" [2] - In 2024, the company's revenue from overseas self-owned brands is expected to increase by 46.07%, with overseas revenue accounting for 18.89% of total income. This indicates a successful transition from OEM to self-owned brand, capturing more value in the international laboratory consumables supply chain [2] Group 2: Domestic Market - The company is positioned to capitalize on the opportunity for import substitution in the current international trade environment, with a strong first-mover advantage in producing disposable plastic consumables for biological laboratories. The company plans to expand its sales network by establishing 12 offices in China in 2024, enhancing service responsiveness [3] - The company is also targeting industrial clients through high-quality cell factories, serving sectors like biopharmaceuticals and vaccine production. In 2024, sales from cell factory products are projected to grow by approximately 28.55%, indicating strong growth momentum [3] Group 3: Product Development and Cost Efficiency - The company is focused on developing high-end products such as liquid culture media and cell culture bags, while optimizing its product structure. It is also improving manufacturing processes and introducing automation to steadily reduce unit manufacturing costs [4] - The establishment of an intelligent manufacturing base will support the automation upgrade of production lines and the implementation of an intelligent warehousing system, which is expected to enhance order delivery efficiency and support global business demands [4] Group 4: Financial Projections - The company forecasts revenues of 652 million yuan, 772 million yuan, and 919 million yuan for 2025-2027, with year-on-year growth rates of 16.7%, 18.3%, and 19.1% respectively. The projected net profits for the same period are 98 million yuan, 118 million yuan, and 145 million yuan, with growth rates of 35.3%, 20.6%, and 23.2% respectively [4]

Investment Rating - The investment rating for the company is "Buy" [2] Core Views - The report highlights that the company has over 20 years of experience in the biological laboratory consumables sector, focusing on biological culture and liquid handling, with leading technical strength and a comprehensive product matrix. The company is expected to maintain rapid growth as its influence in overseas markets increases and both domestic industrial and research markets expand [3][4][5] Summary by Sections 1. Overseas Market - The company has entered the global biological laboratory consumables supply chain through an ODM model, establishing stable partnerships with international leaders like VWR and Thermo Fisher. The company has built a reputation for "reliable quality" and "outstanding cost performance," with overseas self-brand revenue increasing by 46.07% year-on-year in 2024, accounting for 18.89% of total revenue [4][14] 2. Domestic Market - The company is well-positioned to capitalize on the opportunity for import substitution in the current international trade climate. As one of the earliest producers of disposable plastic consumables in China, the company is expanding its sales network and has established 12 offices domestically in 2024. The sales of its cell factory products are expected to grow by approximately 28.55% year-on-year [5][49][53] 3. Product High-Endization and Smart Manufacturing - The company is focused on developing high-end products such as liquid culture media and cell culture bags while optimizing production processes to reduce manufacturing costs. The establishment of an intelligent manufacturing base is expected to enhance order delivery efficiency and support global business needs [6][15] 4. Financial Forecast and Investment Recommendation - The company is projected to achieve revenues of 652 million yuan, 772 million yuan, and 919 million yuan from 2025 to 2027, with year-on-year growth rates of 16.7%, 18.3%, and 19.1% respectively. The net profit attributable to the parent company is expected to be 98 million yuan, 118 million yuan, and 145 million yuan during the same period, with corresponding growth rates of 35.3%, 20.6%, and 23.2% [6][8][20]

Core Viewpoint - Yiqiao Shenzhou (301047) announced on September 4 that its current main product is liquid culture media, targeting the research sector, including research institutions and industrial clients' front-end research needs [1] Group 1: Company Overview - The company is experiencing an increase in sales volume of its culture media [1] - The company faces industry price competition, which is affecting the revenue scale and profit margins of related products [1]